With the Supreme Court set to hear Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., key questions are coming into focus. How might the Court's decision reshape strategies for brand-name and generic manufacturers? And what risks will companies face when marketing “skinny label” products?
A new policy brief from the Eira Initiative, "The Economics of Skinny Labels," explores these issues -- and examines what’s at stake for patients, generic manufacturers, innovators, and policymakers.
The bottom line: The best path forward preserves timely generic entry while maintaining strong incentives for post-approval innovation.
Innovation
Launch of the Journal of Dynamic Competition
The Journal of Dynamic Competition (JDC) debuted on March 27, 2026 at the ABA Antitrust Spring Meeting in Washington, DC.
JDC is an open‑access journal published by World Scientific focused on advancing scholarship at the intersection of competition, innovation, and economic dynamics.
As co-founders and co‑editors, Professor David Teece and Professor Nicolas Petit are excited to help build a forum for rigorous and timely perspectives on how competition policy and strategy evolve in fast‑changing markets.
The journal and its inaugural content are freely available online.